Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Differential responsiveness to belimumab (BmAb) in combination with standard of care therapy in RF plus , TNF alpha-inhibitor and methotrexate partial responder subgroups of subjects with moderate-severe rheumatoid arthritis Genovese, M., Filipowicz-Sosnowska, A., Merrill, J., Wasko, M., Dilorio, E., Stevenson, J., Lisse, J., Zhong, J., Hall, L., Bieber, F., Zilberstein, M., LBRA01 Study Grp WILEY-BLACKWELL. 2005: S738
View details for Web of Science ID 000232207803534